Table 1.

Characteristics of human failing permeabilized myocytes before and after PKA

Human
samples
Myofibrillar preparations
BeforeAfter PKA
n 
Fiber length (µm) 153 ± 8 
Fiber width (µm) 27 ± 2 
Resting sarcomere length (µm) 2.20 ± 0.02 
Passive force (µN) 0.53 ± 0.08 0.58 ± 0.08 
Passive tension (kN/m21.32 ± 0.18 1.39 ± 0.14 
Max force (µN) 14.0 ± 2.3 14.7 ± 2.2 
Max tension (kN/m230.9 ± 3.5 36.6 ± 4.6a 
ktr @ pCa 4.5 (s−10.515 ± 0.04 0.666 ± 0.04a 
pCa for half-maximal force 6.06 ± 0.03 5.96 ± 0.03 
Relative force (PO/P4.50.50 ± 0.04 0.52 ± 0.04 
a/PO 0.16 ± 0.04 0.20 ± 0.07 
Fopt (P/PO0.25 ± 0.02 0.27 ± 0.02 
Vopt (ML/s) 0.100 ± 0.012 0.117 ± 0.009 
Vmax 0.45 ± 0.09 0.47 ± 0.07 
PNPO (P/PO*ML/s) 0.024 ± 0.002 0.031 ± 0.002a 
Submax ktr 0.456 ± 0.05 0.468 ± 0.05 
Human
samples
Myofibrillar preparations
BeforeAfter PKA
n 
Fiber length (µm) 153 ± 8 
Fiber width (µm) 27 ± 2 
Resting sarcomere length (µm) 2.20 ± 0.02 
Passive force (µN) 0.53 ± 0.08 0.58 ± 0.08 
Passive tension (kN/m21.32 ± 0.18 1.39 ± 0.14 
Max force (µN) 14.0 ± 2.3 14.7 ± 2.2 
Max tension (kN/m230.9 ± 3.5 36.6 ± 4.6a 
ktr @ pCa 4.5 (s−10.515 ± 0.04 0.666 ± 0.04a 
pCa for half-maximal force 6.06 ± 0.03 5.96 ± 0.03 
Relative force (PO/P4.50.50 ± 0.04 0.52 ± 0.04 
a/PO 0.16 ± 0.04 0.20 ± 0.07 
Fopt (P/PO0.25 ± 0.02 0.27 ± 0.02 
Vopt (ML/s) 0.100 ± 0.012 0.117 ± 0.009 
Vmax 0.45 ± 0.09 0.47 ± 0.07 
PNPO (P/PO*ML/s) 0.024 ± 0.002 0.031 ± 0.002a 
Submax ktr 0.456 ± 0.05 0.468 ± 0.05 

Mechanical properties were tested before and after PKA treatment and compared via paired t test analysis. Values are mean ± SEM.

a

P ≤ 0.05. n equals the number of human hearts (biological replicates), with one cardiac myocyte preparation per heart.

or Create an Account

Close Modal
Close Modal